WHAT ARE MAST CELL DISEASES?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Mast cells are essential effector cells involved in host defense, tissue homeostasis, and the pathogene-sis of numerous allergic and inflammatory diseases. Mast cell disorders represent a rare but clinically broad and heterogeneous group of conditions characterized by clonal proliferation, abnormal accu-mulation, and/or inappropriate activation of mast cells. In recent years, numerous novel biomarkers with diagnostic, prognostic, and predictive value have been identified for mast cell neoplasms and mast cell activation syndromes. In parallel, international consensus groups have substantially updated the classification of mast cell disorders. In current classifications, mast cell disorders are classified as primary mast cell disorders, secondary mast cell disorders, and mast cell activation syndromes. The mastocytosis spectrum encompasses primary mast cell disorders and consists of two main categories: cutaneous mastocytosis and systemic mastocytosis. Within cutaneous mastocytosis, maculopapular cutaneous mastocytosis is the most frequently observed form, whereas indolent systemic mastocy-tosis represents the most common subtype of systemic mastocytosis. Secondary mast cell disorders are classified into two categories: IgE-mediated, which causes rapid degranulation and anaphylaxis, and non-IgE-mediated, involving alternative activation pathways that drive chronic mediator release and low-grade inflammation. Non-IgE-mediated disorders include chronic atopic and inflammatory conditions characterized by mast cell dysfunction, vascular remodeling, and altered responses to hy-poxia. Mast cell activation syndromes (MCAS) comprise a heterogeneous group. MCAS is diagnosed by clinical symptoms attributable to episodic mast cell activation involving multiple organ systems, biochemical evidence of mast cell activation, and a documented clinical response to mast cell–directed therapies. MCAS is classified into subtypes, including primary, secondary, idiopathic, and hereditary alpha-tryptasemia–associated forms. This classification enables a comprehensive management of asso-ciated diseases alongside appropriate treatment strategies, allowing for a reduction in morbidity and an improvement in patients’ quality of life.
Fields of Study & Subjects
Mast cells and histamine
Eosinophilic Disorders and Syndromes
Congenital gastrointestinal and neural anomalies
Publication details
- Journal / source
- Turkiye Klinikleri eBooks
- Pages
- 47–57
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Book chapter